<?xml version="1.0" encoding="UTF-8"?>
<ref id="R47">
 <label>47. </label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Ball</surname>
   <given-names>JP</given-names>
  </string-name>, 
  <string-name>
   <surname>Springer</surname>
   <given-names>MJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Ni</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Finger-Baker</surname>
   <given-names>I</given-names>
  </string-name>, 
  <string-name>
   <surname>Martinez</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>Hahn</surname>
   <given-names>J</given-names>
  </string-name>, 
  <etal>et al.</etal>
  <article-title>Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.</article-title>
  <source>PLoS One</source>. 
  <year>2017</year>;
  <volume>12</volume>:
  <elocation-id>e0177310</elocation-id>. 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0177310</pub-id>
  <?supplied-pmid 28545100?>
  <pub-id pub-id-type="pmid">28545100</pub-id>
 </mixed-citation>
</ref>
